Ipatasertib Completed Phase 1 Trials for Solid Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01090960A Study Evaluating the Safety and Tolerability of GDC-0068 in Patients With Refractory Solid Tumors